Study at a glance
Can human immune cells make active vitamin D themselves?
Researchers studied human immune cells called macrophages grown in the laboratory. They placed the cells in different experimental states and supplied 25-hydroxyvitamin D, a form that can be converted into active vitamin D. Chemical tests measured the compounds produced. The researchers also examined activity of genes for enzymes that process vitamin D.
Which immune-cell group activated the most vitamin D?
The cells produced directly measurable active vitamin D outside the kidneys. The amount depended strongly on the state of the cells. A group labelled M2a showed the strongest activation, while an inflammatory group labelled M1 processed comparatively little of the supplied vitamin D. The cells also processed vitamin D through other routes, so activation was not the only change taking place.
Why measure active vitamin D rather than just an activating enzyme?
Finding an enzyme alone would show only that conversion might be possible. Measuring active vitamin D itself showed that conversion had occurred in this experiment. The differences between cell groups also showed that the amount of starting material alone did not determine the result. The condition of the cells mattered.
Do these cell findings show that immune cells can replace the kidneys’ role?
Cells grown in the laboratory do not experience every influence present in living tissues. The study did not measure how much macrophages contribute to active vitamin D in a person’s blood, or show that all tissues behave alike. It does not establish supplement doses, personal blood targets or a replacement for the kidneys’ role. The finding concerns local activation in the cells and conditions tested.
Read the full article below ↓This evidence review examines a primary human-cell study investigating extra-renal vitamin D metabolism in monocyte-derived macrophages. The researchers supplied human macrophages with 25-hydroxyvitamin D [25(OH)D] and directly measured production of vitamin D metabolites, including the active metabolite 1,25-dihydroxyvitamin D [1,25(OH)2D], using liquid chromatography: tandem mass spectrometry (LC-MS/MS). They also measured expression of CYP27B1, the enzyme responsible for converting 25(OH)D to 1,25(OH)2D, together with other components of vitamin D metabolism. The study provides direct evidence that human macrophages can perform extra-renal vitamin D activation and shows that this metabolic capacity varies substantially according to macrophage phenotype.
Study classification and identity
Study type: Primary experimental human-cell study of vitamin D metabolism in monocyte-derived macrophages.
Population or experimental system: Human monocytes differentiated into macrophages and polarised into different functional phenotypes, including inflammatory M1 and alternatively activated M2a macrophages.
Parent study or cohort: Not applicable.
Ancillary analysis: Gene-expression measurements were used alongside direct metabolite analysis to characterise the vitamin D metabolic machinery associated with different macrophage phenotypes.
Exposure or intervention: Cultured human macrophages were supplied with 25(OH)D as substrate, allowing the researchers to determine whether different macrophage phenotypes converted the precursor into active and other vitamin D metabolites.
Comparison or grouping structure: Vitamin D metabolism was compared across macrophages with different functional phenotypes, with particular attention to differences between M1 and M2a macrophages.
Primary endpoint category: Extra-renal metabolism of 25(OH)D and production of 1,25(OH)2D by human macrophages.
Study purpose and research question
The researchers sought to determine how human macrophage phenotype influences vitamin D metabolism. Macrophages can express CYP27B1 outside the kidney, creating the possibility that circulating 25(OH)D can be converted locally into active 1,25(OH)2D within immune-cell environments.
The central question was not simply whether macrophages possess CYP27B1. The researchers directly investigated what happened to supplied 25(OH)D and whether the resulting metabolite profile differed according to macrophage functional state.
For this evidence slot, the relevant territory is extra-renal activation in peripheral tissues. The study fits that territory particularly well because it uses human cells and directly measures formation of active vitamin D from its circulating precursor rather than inferring activation solely from enzyme expression.
Study overview
Human monocytes were differentiated into macrophages and exposed to conditions producing distinct macrophage phenotypes. The researchers then supplied 25(OH)D and examined how those cells metabolised the precursor.
Vitamin D metabolites were measured directly using LC-MS/MS. This analytical approach allowed the investigators to distinguish production of active 1,25(OH)2D from other metabolic products rather than treating CYP27B1 expression as a substitute for actual metabolite formation.
The metabolic response differed substantially according to macrophage phenotype. M2a macrophages demonstrated particularly strong conversion of 25(OH)D into active 1,25(OH)2D, whereas inflammatory M1 macrophages showed comparatively little metabolism of the supplied precursor.
The investigators also examined expression of enzymes involved in vitamin D metabolism. These molecular measurements provided mechanistic context for the directly observed differences in metabolite production.
Study design and measurement approach
The experimental design combined controlled macrophage differentiation and polarisation with direct analysis of vitamin D metabolites. This allowed the investigators to ask whether changing cellular phenotype altered the way the same vitamin D precursor was processed.
After macrophages were supplied with 25(OH)D, LC-MS/MS was used to analyse vitamin D metabolites generated by the cells. Direct measurement of 1,25(OH)2D was especially important because it established that extra-renal activation had actually occurred.
Gene-expression analysis complemented the metabolite measurements by examining relevant components of the vitamin D metabolic system, including CYP27B1 and pathways associated with further metabolism of vitamin D compounds.
The resulting design therefore connected cellular phenotype, metabolic-enzyme expression and directly measured metabolite production within the same experimental framework.
For the cellular framework underlying vitamin D metabolism, see Vitamin D Metabolism at the Cellular Level.
What the study directly measured
The study directly measured metabolism of supplied 25(OH)D by human monocyte-derived macrophages. LC-MS/MS demonstrated formation of vitamin D metabolites, including active 1,25(OH)2D.
The investigators found marked differences between macrophage phenotypes. M2a macrophages showed the strongest activation of supplied 25(OH)D, producing substantially more 1,25(OH)2D than the other investigated phenotypes.
Inflammatory M1 macrophages showed comparatively little metabolism of the supplied 25(OH)D. This demonstrated that possession of a potential vitamin D metabolic pathway does not mean that all macrophage states process precursor identically.
The study also measured molecular components associated with vitamin D metabolism, allowing the observed metabolite profiles to be interpreted alongside differences in cellular metabolic machinery.
What the study did not directly measure
The experiment did not measure whole-body vitamin D activation in living humans. The cells were studied under controlled culture conditions, so the results establish metabolic capacity within the experimental macrophage system rather than the quantitative contribution of macrophages to circulating vitamin D metabolites in vivo.
The study did not establish that all extra-renal tissues activate vitamin D in the same manner. Macrophages provide one important example of peripheral cellular metabolism, but their behaviour cannot automatically be generalised to every tissue expressing CYP27B1.
Nor did the experiment establish that circulating 25(OH)D concentrations alone determine local production of active vitamin D. The substantial differences between macrophage phenotypes demonstrate that cellular state is an important part of the metabolic response.
What cannot be inferred from this study
The findings cannot be used to calculate an individual’s vitamin D requirement, supplementation dose or target blood concentration. This was a mechanistic cellular experiment rather than a clinical supplementation trial.
Direct production of 1,25(OH)2D by macrophages also does not establish that macrophage-derived active vitamin D materially raises circulating 1,25(OH)2D concentrations in healthy people. Local production and systemic endocrine production are related areas of vitamin D biology but are not equivalent.
The findings should therefore be interpreted as evidence for extra-renal metabolic capability and phenotype-dependent regulation, not as evidence that peripheral activation replaces or duplicates the physiological role of renal vitamin D activation.
Statistical and analytical approach
The study combined direct metabolite quantification with molecular measurements and comparisons among experimentally generated macrophage phenotypes. LC-MS/MS provided analytical separation and quantification of vitamin D metabolites, while gene-expression methods characterised relevant metabolic enzymes.
Comparisons between macrophage states were used to determine whether cellular phenotype was associated with materially different patterns of 25(OH)D metabolism. The interpretation therefore depends on both the direct chemical measurements and the controlled experimental differences between macrophage phenotypes.
As with other cell-culture experiments, individual experimental comparisons should be interpreted within their specific conditions rather than treated as population estimates of vitamin D metabolism in living humans.
Results
The central result was direct demonstration that human macrophages can convert supplied 25(OH)D into active 1,25(OH)2D outside the kidney. The active metabolite was chemically measured rather than inferred solely from expression of CYP27B1.
The magnitude of this activation differed markedly with macrophage phenotype. M2a macrophages displayed particularly strong production of 1,25(OH)2D, demonstrating substantial extra-renal activation under that cellular condition.
By contrast, inflammatory M1 macrophages showed comparatively little metabolism of the supplied precursor. The same substrate therefore produced very different metabolic outcomes depending on the functional state of the macrophage.
The study also identified metabolism through pathways other than production of 1,25(OH)2D. This is important because cellular vitamin D metabolism involves a balance among activation, further hydroxylation and other metabolic routes rather than a single one-way conversion.
Taken together, the metabolite and molecular findings demonstrate that extra-renal vitamin D metabolism is biologically regulated and strongly influenced by cellular phenotype.
Measurement considerations and study limitations
A major strength of the study is direct metabolite measurement. Detection of 1,25(OH)2D by LC-MS/MS provides stronger evidence of activation than CYP27B1 expression alone because expression of an enzyme does not necessarily establish the quantity of metabolic product actually generated.
The principal limitation is experimental context. These were human cells studied outside the intact human body. Culture conditions allow metabolic mechanisms to be isolated and tested, but they cannot reproduce every influence present within living tissues.
The macrophage phenotypes were also experimentally generated states. Their metabolic differences demonstrate that cellular state can alter vitamin D metabolism, but the magnitude of those differences should not automatically be treated as a quantitative estimate of macrophage behaviour throughout the human body.
Finally, direct local production of active vitamin D does not establish its systemic contribution. The experiment demonstrates cellular capability and regulation but does not quantify how much macrophage metabolism contributes to circulating active vitamin D in vivo.
Generalisability and population context
The study is directly relevant to human cellular biology because the experimental system used human monocyte-derived macrophages. This avoids the species-translation issue inherent in animal models when establishing whether human macrophages themselves possess the relevant metabolic capability.
However, human-cell origin does not make a cell-culture experiment equivalent to a study conducted in intact humans. The findings establish what these cells can do under the tested conditions and how that capability changes with phenotype.
The broader generalisable principle is therefore that extra-renal vitamin D activation can occur in human peripheral cells and that the extent of this activation can depend strongly on cellular state.
Mechanistic inference boundary
The strongest mechanistic conclusion is that human macrophages can use 25(OH)D as substrate for extra-renal production of active 1,25(OH)2D and that this metabolic process varies according to macrophage phenotype.
The direct detection of active metabolite establishes conversion within the experimental system. Differences between macrophage states further demonstrate that precursor availability alone does not determine the amount of active vitamin D produced.
The experiment does not establish the quantitative contribution of this pathway to systemic vitamin D endocrinology, nor does it establish equivalent behaviour in every CYP27B1-expressing peripheral tissue.
For the broader comparison of vitamin D metabolism between tissues, see Tissue-Specific Vitamin D Metabolism.
Interpretation within vitamin D physiology
This study provides direct experimental support for an important extension of the conventional liver: kidney activation pathway. The kidney is a major regulated site of active-vitamin-D production, but it is not the only location in which 25(OH)D can be converted to 1,25(OH)2D.
Human macrophages can perform this conversion locally. Moreover, their ability to do so is not fixed. Different macrophage phenotypes processed the same supplied precursor very differently, demonstrating that cellular context influences the metabolic fate of 25(OH)D.
This supports a layered view of vitamin D activation in which circulating 25(OH)D provides substrate that can be metabolised differently according to the biological environment in which it is encountered.
For the parent physiology framework, see Vitamin D Activation.
Evidence boundaries and final interpretation
The strongest defensible interpretation is that the study directly demonstrated extra-renal conversion of 25(OH)D into active 1,25(OH)2D by human monocyte-derived macrophages and showed that this capacity differed substantially among macrophage phenotypes.
The particularly strong activation observed in M2a macrophages, contrasted with comparatively little metabolism in inflammatory M1 macrophages, demonstrates that cellular functional state can materially influence local vitamin D metabolism.
The principal evidence boundary is that these findings arise from an experimental human-cell system. They establish cellular metabolic capability and phenotype-dependent regulation but do not quantify the contribution of macrophage-derived 1,25(OH)2D to whole-body vitamin D physiology in living humans.
For a concise explanation of this study, see Extra-Renal Vitamin D Activation: Study Summary.
Primary source and publication details
Primary research article examining vitamin D metabolism in human monocyte-derived macrophage phenotypes.
The verified primary source used for this evidence review should remain the sole authority for study-specific methodological, quantitative and experimental claims on this page.
Related reading
1,25-dihydroxyvitamin D deficiency is independently associated with cardiac valve calcification in patients with chronic kidney disease
The associations between AVC and MVC and baseline variables were investigated using logistic regression analyses.
Original paper ↗Read more →Active Vitamin D and Vitamin D Receptor Help Prevent High Glucose Induced Oxidative Stress of Renal Tubular Cells via AKT/UCP2 Signaling Pathway
JC-1 was evaluated by flow cytometry.
Original paper ↗Read more →Assessment of Serum 25-Hydroxyvitamin D and Its Association in Type 2 Diabetes Mellitus Elderly Patients with Kidney Disease: A Retrospective Cross Sectional Study
The overall aim of this study is to determine the prevalence of vitamin D deficiency and its association with diabetic nephropathy in elderly patients with type 2 diabetes mellitus.
Original paper ↗Read more →Association of serum vitamin D level with age in individuals with normal renal function
The aim of this study was to investigate the association of serum 25-hydroxy vitamin D (25[OH]D) concentrations with age of Iranian healthy individuals.
Original paper ↗Read more →Combined assessment of 25(OH)D, CD4+/CD8+ ratio, and prognostic nutritional index for anti-dsDNA-based stratification in systemic lupus erythematosus
Clinical characteristics and laboratory parameters, including 25(OH)D, CD4+/CD8+ ratio, and PNI, were compared among groups.
Original paper ↗Read more →Delta corticomedullary apparent diffusion coefficient on MRI as a biomarker for prognosis in IgA nephropathy
Clinicopathological characteristics were compared according to different ΔADC levels.
Original paper ↗Read more →Effect of Calcitriol on the Renal Microvasculature Differentiation Disturbances Induced by AT1 Blockade During Nephrogenesis in Rats
We evaluated the effects of calcitriol administration on losartan [angiotensin II receptor antagonist (ANGII), AT1]-induced changes in renal differentiation in rats during lactation.
Original paper ↗Read more →Efficacy and Safety of the Use of SGLT2 Inhibitors in Patients on Incremental Hemodialysis: Maximizing Residual Renal Function, Is There a Role for SGLT2 Inhibitors?
SGLT-2i are the new standard of care for diabetic kidney disease (DKD), but previous studies have not included patients on kidney replacement therapy (KRT).
Original paper ↗Read more →Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes
The definitive treatment for end-stage renal disease is kidney transplantation, which remains limited by organ availability and post-transplant complications.
Original paper ↗Read more →High Levels of Galectin-3 and Uric Acid Are Independent Predictors of Renal Impairment in Patients with Stable Coronary Artery Disease
High plasma levels of Galectin-3 (Gal-3) and uric acid (UA) are associated with a decline in renal function in different populations.
Original paper ↗Read more →L-shaped association of serum 25-hydroxyvitamin D with all-cause and cardiovascular mortality in older people with chronic kidney disease: results from the NHANES database prospective cohort study
We identified 3230 CKD participants aged ≥ 60 years from the National Health and Nutrition Examination Survey (2001 to 2018).
Original paper ↗Read more →Metabolism of 25-Hydroxy-Vitamin D in Human Macrophages Is Highly Dependent on Macrophage Polarization
We found that reparative MDMs (M2a) had significantly more 1,25-dihydroxy-vitamin D compared to the other MDMs (M0, M1 and M2c).
Original paper ↗Read more →Nephroprotective effect of vitamin D Against Levofloxacin-induced renal injury: an observational study
In this study, we evaluated the effects of synthetic vitamin D on levofloxacin-induced renal injury in rats.
Original paper ↗Read more →Protective Role of Vitamin D in Renal Tubulopathies
Vitamin D is tightly linked with renal tubular homeostasis: the mitochondria of proximal convoluted tubule cells are the production site of 1α,25-dihydroxyvitamin D3.
Original paper ↗Read more →Renal complications in patients with chronic hypoparathyroidism on conventional therapy: a systematic literature review
In patients who receive long-term treatment with oral calcium and active vitamin D, chronic hypoparathyroidism may be associated with an increased risk of renal complications compared with the general population.
Original paper ↗Read more →Renal Endocytic Regulation of Vitamin D Metabolism during Maturation and Aging in Laying Hens
Therefore, the present study aimed to examine the expression and localization of Meg and CUB in the kidneys of immature chicks and mature and aged laying hens to prevent eggshell quality deterioration.
Original paper ↗Read more →Serum 25(OH)D levels are associated with disease activity and renal involvement in initial-onset childhood systemic lupus erythematosus
Compared with the controls (25.53 ± 7.02 ng/ml), patients with initial-onset SLE during childhood have lower serum 25(OH)D levels (18.63 ± 5.32 ng/ml) (P.
Original paper ↗Read more →Urinalysis of individuals with renal hyperfiltration using ATR-FTIR spectroscopy
Abnormal increased glomerular filtration rate (GFR), otherwise known as renal hyperfiltration (RHf), is associated with an increased risk of chronic kidney disease and cardiovascular mortality.
Original paper ↗Read more →Vitamin D alleviates lead induced renal and testicular injuries by immunomodulatory and antioxidant mechanisms in rats
The co-administration of VD with Pb markedly mitigated renal and testicular injuries compared with positive controls.
Original paper ↗Read more →Vitamin D3 and erythropoietin protect against renal ischemia-reperfusion injury via heat shock protein 70 and microRNA-21 expression
We investigated the effects of vitamin D3 (Vit D) and erythropoietin (EPO) on microRNA-21(miR-21) expression in renal IR.
Original paper ↗Read more →Vitamin D3 Metabolic Enzymes in the Porcine Uterus: Expression, Localization and Autoregulation by 1,25(OH)2D3 In Vitro
This study aimed to examine vitamin D3 metabolic enzymes, i.e., CYP27B1 and CYP24A1, mRNA transcript and protein abundance, and protein localization in the uterus of pigs on days 2 to 5, 10 to 12, 15 to 16 and 18 to 20 of the estrous cycle.
Original paper ↗Read more →Original sources
Metabolism of 25-Hydroxy-Vitamin D in Human Macrophages Is Highly Dependent on Macrophage Polarization
We found that reparative MDMs (M2a) had significantly more 1,25-dihydroxy-vitamin D compared to the other MDMs (M0, M1 and M2c).
Publication details
Nygaard RH, Nielsen MC, Antonsen KW, Højskov CS, Sørensen BS, Møller HJ. (2022). Metabolism of 25-Hydroxy-Vitamin D in Human Macrophages Is Highly Dependent on Macrophage Polarization. International Journal of Molecular Sciences, 23(18), 10943. DOI: 10.3390/ijms231810943. PMID: 36142855. PMCID: PMC9505540.